The anticancer activity of propolis

193Citations
Citations of this article
271Readers
Mendeley users who have this article in their library.

Abstract

Propolis and its compounds have been the subject of many studies due to their antimicrobial and antiinflammatory activity; however, it is now known that they also possess antitumor properties. This review aims to summarize the results of studies on the mechanism of activity of propolis and its active compounds such as CAPE and chrysin in the apoptotic process, and their influence on the proliferation of cancer cells. Our review shows that propolis and its presented compounds induce apoptosis pathways in cancer cells. The antiproliferative effects of propolis, CAPE or chrysin in cancer cells are the result of the suppression of complexes of cyclins, as well as cell cycle arrest. The results of in vitro and in vivo studies suggest that propolis, CAPE and chrysin may inhibit tumor cell progression and may be useful as potential chemotherapeutic or chemopreventive anticancer drugs. © Polish Society for Histochemistry and Cytochemistry.

Cite

CITATION STYLE

APA

Sawicka, D., Car, H., Borawska, M. H., & Nikliński, J. (2012). The anticancer activity of propolis. Folia Histochemica et Cytobiologica. Via Medica. https://doi.org/10.5603/FHC.2012.0004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free